Basel Medical Group Stock Market Value
| BMGL Stock | 0.49 0.03 5.77% |
| Symbol | Basel |
Basel Medical Group Price To Book Ratio
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. If investors know Basel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Basel Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth 0.322 | Return On Assets | Return On Equity |
The market value of Basel Medical Group is measured differently than its book value, which is the value of Basel that is recorded on the company's balance sheet. Investors also form their own opinion of Basel Medical's value that differs from its market value or its book value, called intrinsic value, which is Basel Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Basel Medical's market value can be influenced by many factors that don't directly affect Basel Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Basel Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Basel Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Basel Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Basel Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Basel Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Basel Medical.
| 06/09/2024 |
| 12/31/2025 |
If you would invest 0.00 in Basel Medical on June 9, 2024 and sell it all today you would earn a total of 0.00 from holding Basel Medical Group or generate 0.0% return on investment in Basel Medical over 570 days. Basel Medical is related to or competes with P3 Health, Vicarious Surgical, Longduoduo Company, Precipio, IBio, Common, Nutriband, and Iterum Therapeutics. Basel Medical is entity of United States More
Basel Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Basel Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Basel Medical Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.28) | |||
| Maximum Drawdown | 42.69 | |||
| Value At Risk | (11.63) | |||
| Potential Upside | 6.62 |
Basel Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Basel Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Basel Medical's standard deviation. In reality, there are many statistical measures that can use Basel Medical historical prices to predict the future Basel Medical's volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (1.71) | |||
| Total Risk Alpha | (2.19) | |||
| Treynor Ratio | (1.97) |
Basel Medical Group Backtested Returns
Basel Medical Group secures Sharpe Ratio (or Efficiency) of -0.27, which signifies that the company had a -0.27 % return per unit of risk over the last 3 months. Basel Medical Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Basel Medical's Mean Deviation of 3.98, risk adjusted performance of (0.18), and Standard Deviation of 6.12 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.84, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Basel Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Basel Medical is expected to be smaller as well. At this point, Basel Medical Group has a negative expected return of -1.65%. Please make sure to confirm Basel Medical's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Basel Medical Group performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.17 |
Very weak predictability
Basel Medical Group has very weak predictability. Overlapping area represents the amount of predictability between Basel Medical time series from 9th of June 2024 to 21st of March 2025 and 21st of March 2025 to 31st of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Basel Medical Group price movement. The serial correlation of 0.17 indicates that over 17.0% of current Basel Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Basel Medical Group lagged returns against current returns
Autocorrelation, which is Basel Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Basel Medical's stock expected returns. We can calculate the autocorrelation of Basel Medical returns to help us make a trade decision. For example, suppose you find that Basel Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Basel Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Basel Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Basel Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Basel Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Basel Medical Lagged Returns
When evaluating Basel Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Basel Medical stock have on its future price. Basel Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Basel Medical autocorrelation shows the relationship between Basel Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Basel Medical Group.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Basel Medical Correlation, Basel Medical Volatility and Basel Medical Alpha and Beta module to complement your research on Basel Medical. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Basel Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.